Vascular medicine and thrombectomy in stroke

Area of Science:

• Neurology
• Neurosurgery
• Vascular Medicine

Background:

• Intravenous recombinant tissue plasminogen activator (rt-PA) was the sole evidence-based treatment for intracranial vessel occlusion-induced stroke.
• The efficacy of rt-PA was limited, particularly in cases of large vessel occlusions, showing disappointing response rates.

Purpose of the Study:

• To review the current status of mechanical thrombectomy for acute ischemic stroke.
• To discuss future expectations and challenges in the field of mechanical thrombectomy for stroke treatment.

Main Methods:

• Review of five key studies published in 2015 evaluating mechanical thrombectomy efficacy.
• Analysis of clinical benefits demonstrated in selected acute ischemic stroke patients.

Main Results:

• Mechanical thrombectomy demonstrated significant clinical benefit in selected patients with acute ischemic stroke.
• These findings have driven substantial changes in neurovascular stroke treatment infrastructure and practices.

Conclusions:

• Mechanical thrombectomy has emerged as a crucial treatment for acute ischemic stroke due to large vessel occlusions.
• Ongoing advancements and addressing challenges are vital for optimizing future stroke care.